MIGDAL HA'EMEQ, Israel, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the Company will release financial results for the third quarter ended September 30, 2014 on Thursday, November 13, 2014, before the market opens. Following the release, Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer will host a conference call to review the financial results.
The conference call is scheduled to begin at 8:30 a.m. ET on Thursday, November 13, 2014. Participants should dial 877-359-9508 (United States) or 224-357-2393 (International) with confirmation code 28675441 to access the live call. The call will also be broadcast live over the Internet, hosted in the Investors section of Enzymotec's website at http://ir.enzymotec.com, and will be archived online within one hour of its completion through November 20, 2014.
A dial-in replay of the call will also be available to those interested until November 20, 2014. To access the replay, dial 855-859-2056 (United States) or 404-537-3406 (International) and enter code 28675441.
About Enzymotec Ltd.
Enzymotec Ltd. is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies. For more information, visit www.enzymotec.com.
CONTACT: KCSA Strategic Communications Jeffrey Goldberger / Robert Fink 212.896.1249 / 212.896.1206 ENZY@kcsa.com